US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

GRACE THERAPEUTICS INC

3.11

+0.09002.98%

Volume:196.53K

Turnover:618.25K

Market Cap:43.01M

PE:-4.02

High:3.22

Open:2.98

Low:2.98

Close:3.02

52wk High:4.97

52wk Low:1.75

Shares:13.83M

Float Shares:7.48M

Volume Ratio:2.24

T/O Rate:2.63%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.7733

EPS(LYR):-0.7916

ROE:-16.78%

ROA:-13.26%

PB:0.68

PE(LYR):-3.93

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Grace Therapeutics announces presentation of Phase 3 STRIVE-ON safety trial

Grace Therapeutics Pivotal Phase 3 Strive-on Safety Trial Presented at 2025 Neurocritical Care Annual Meeting

THOMSON REUTERS

Grace Therapeutics Inc. Held Annual Stockholders Meeting

Grace Therapeutics Inc. Unveils Presentation on GTx-104 for aSAH Treatment, Highlighting Phase 3 Trial Success and Upcoming NDA Review

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/GRCE"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"GRCE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GRCE\",,,,,undefined,":{"symbol":"GRCE","market":"US","secType":"STK","nameCN":"GRACE THERAPEUTICS INC","latestPrice":3.11,"timestamp":1760557296739,"preClose":3.02,"halted":0,"volume":196526,"delay":0,"floatShares":7481784,"shares":13828562,"eps":-0.773304,"marketStatus":"Trading","change":0.09,"latestTime":"10-15 15:44:06 EDT","open":2.98,"high":3.22,"low":2.98,"amount":618254.7594784,"amplitude":0.07947,"askPrice":3.19,"askSize":11,"bidPrice":3.1,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-0.773304,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1760558400000},"marketStatusCode":2,"adr":0,"listingDate":1357534800000,"exchange":"NASDAQ","adjPreClose":3.02,"preHourTrading":{"tag":"盘前","latestPrice":2.97,"preClose":3.02,"latestTime":"09:09 EDT","volume":16,"amount":47.6908,"timestamp":1760533789637},"postHourTrading":{"tag":"盘后","latestPrice":3.01,"preClose":3.01,"latestTime":"19:11 EDT","volume":64,"amount":191.88,"timestamp":1760483494605},"volumeRatio":2.242743},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GRCE\",,,,,undefined,":{"symbol":"GRCE","floatShares":7481784,"roa":"-13.26%","roe":"-16.78%","lyrEps":-0.791576,"volumeRatio":2.242743,"shares":13828562,"dividePrice":0,"high":3.22,"amplitude":0.07947,"preClose":3.02,"low":2.98,"week52Low":1.75,"pbRate":"0.68","week52High":4.965,"institutionHeld":0,"latestPrice":3.11,"committee":0.801802,"eps":-0.773304,"divideRate":0,"volume":196526,"delay":0,"ttmEps":-0.773304,"open":2.98,"prevYearClose":3.74,"prevWeekClose":2.99,"prevMonthClose":2.977,"prevQuarterClose":2.977,"fiveDayClose":3.003,"twentyDayClose":3.06,"sixtyDayClose":3.35},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GRCE\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-08-12","symbol":"GRCE","fiscalQuarterEnding":"2025/06","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1754971200000,"reportTimeType":"","actualEps":-0.21},{"market":"US","date":"2025-06-23","symbol":"GRCE","fiscalQuarterEnding":"2025/03","expectedEps":-0.2,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1750651200000,"reportTimeType":"pre","actualEps":-0.21},{"market":"US","date":"2025-02-13","symbol":"GRCE","fiscalQuarterEnding":"2024/12","expectedEps":-0.24,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1739422800000,"reportTimeType":"pre","actualEps":-0.26},{"market":"US","date":"2024-11-13","symbol":"GRCE","fiscalQuarterEnding":"2024/09","expectedEps":-0.33,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731474000000,"reportTimeType":"pre","actualEps":-0.33},{"market":"US","date":"2024-08-09","symbol":"GRCE","fiscalQuarterEnding":"2024/06","expectedEps":-0.28,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1723176000000,"reportTimeType":"pre","actualEps":-0.24}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GRCE\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GRCE\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":2,"updateTime":1746244800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/GRCE\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"GRCE","date":"2025-10-14","current":-4.047567,"percent":0.316456,"low":-4.979034,"twenty":-4.230342,"median":-3.062228,"eighty":-2.602778,"high":-1.653321,"avg":-3.290924,"sd":0.837071,"marketCap":41278257},"quantilePoints":[{"date":"2024-10-31","current":-2.746009,"twenty":-2.84522,"median":-2.808016,"eighty":-2.770812,"marketCap":31433569},{"date":"2024-11-08","current":-2.737151,"twenty":-2.770812,"median":-2.746009,"eighty":-2.701719,"marketCap":31332170},{"date":"2024-11-15","current":-2.891861,"twenty":-2.815988,"median":-2.74158,"eighty":-2.694633,"marketCap":33562939},{"date":"2024-11-22","current":-2.821967,"twenty":-2.824979,"median":-2.746009,"eighty":-2.701719,"marketCap":32751751},{"date":"2024-11-29","current":-2.935545,"twenty":-2.870023,"median":-2.76081,"eighty":-2.701719,"marketCap":34069932},{"date":"2024-12-06","current":-3.791745,"twenty":-2.935545,"median":-2.823849,"eighty":-2.717126,"marketCap":44006996},{"date":"2024-12-13","current":-3.407329,"twenty":-3.407329,"median":-2.865651,"eighty":-2.737151,"marketCap":39545457},{"date":"2024-12-20","current":-3.547117,"twenty":-3.407329,"median":-2.887493,"eighty":-2.746009,"marketCap":41167835},{"date":"2024-12-27","current":-3.232594,"twenty":-3.39335,"median":-2.931176,"eighty":-2.746009,"marketCap":37517485},{"date":"2025-01-03","current":-3.494696,"twenty":-3.396845,"median":-2.953018,"eighty":-2.749647,"marketCap":40559444},{"date":"2025-01-10","current":-3.582064,"twenty":-3.494696,"median":-3.066596,"eighty":-2.755568,"marketCap":41573430},{"date":"2025-01-17","current":-2.935545,"twenty":-3.494696,"median":-3.057859,"eighty":-2.767291,"marketCap":34069932},{"date":"2025-01-24","current":-3.437907,"twenty":-3.492949,"median":-3.145227,"eighty":-2.786004,"marketCap":39900353},{"date":"2025-01-31","current":-2.778283,"twenty":-3.476349,"median":-3.13649,"eighty":-2.78702,"marketCap":32244757},{"date":"2025-02-07","current":-2.918071,"twenty":-3.433539,"median":-3.040386,"eighty":-2.785272,"marketCap":33867135},{"date":"2025-02-14","current":-3.040386,"twenty":-3.416065,"median":-3.038201,"eighty":-2.814977,"marketCap":35286716},{"date":"2025-02-21","current":-2.570989,"twenty":-3.416065,"median":-3.009807,"eighty":-2.777013,"marketCap":34374128},{"date":"2025-02-28","current":-2.29038,"twenty":-3.407329,"median":-2.996702,"eighty":-2.746009,"marketCap":30622380},{"date":"2025-03-07","current":-2.050724,"twenty":-3.407329,"median":-2.952538,"eighty":-2.701719,"marketCap":27418184},{"date":"2025-03-14","current":-1.736745,"twenty":-3.389855,"median":-2.935545,"eighty":-2.613138,"marketCap":23220281},{"date":"2025-03-21","current":-1.941514,"twenty":-3.363645,"median":-2.904966,"eighty":-2.495149,"marketCap":25958044},{"date":"2025-03-28","current":-2.329102,"twenty":-3.337435,"median":-2.883124,"eighty":-2.329102,"marketCap":31140100},{"date":"2025-04-04","current":-2.25728,"twenty":-3.328698,"median":-2.865651,"eighty":-2.3283,"marketCap":30179833},{"date":"2025-04-11","current":-1.99051,"twenty":-3.319961,"median":-2.825732,"eighty":-2.29038,"marketCap":26613125},{"date":"2025-04-17","current":-2.093114,"twenty":-3.278025,"median":-2.81323,"eighty":-2.187348,"marketCap":27984936},{"date":"2025-04-25","current":-2.441966,"twenty":-3.253562,"median":-2.777648,"eighty":-2.187348,"marketCap":32649092},{"date":"2025-05-02","current":-2.780558,"twenty":-3.243078,"median":-2.76081,"eighty":-2.203926,"marketCap":37176067},{"date":"2025-05-09","current":-2.872902,"twenty":-3.234341,"median":-2.778283,"eighty":-2.214186,"marketCap":38410696},{"date":"2025-05-16","current":-2.784047,"twenty":-3.204636,"median":-2.778283,"eighty":-2.249072,"marketCap":37222708},{"date":"2025-05-23","current":-3.04702,"twenty":-3.183669,"median":-2.787433,"eighty":-2.28376,"marketCap":40738659},{"date":"2025-05-30","current":-2.978583,"twenty":-3.159206,"median":-2.802024,"eighty":-2.29493,"marketCap":39823661},{"date":"2025-06-06","current":-3.037068,"twenty":-3.145227,"median":-2.825732,"eighty":-2.310491,"marketCap":40605593},{"date":"2025-06-13","current":-2.996026,"twenty":-3.145227,"median":-2.855425,"eighty":-2.319966,"marketCap":40056869},{"date":"2025-06-20","current":-3.149932,"twenty":-3.145227,"median":-2.867837,"eighty":-2.32375,"marketCap":42114585},{"date":"2025-06-27","current":-4.249161,"twenty":-3.190658,"median":-2.872902,"eighty":-2.328621,"marketCap":40655972},{"date":"2025-07-03","current":-4.523767,"twenty":-3.242086,"median":-2.883124,"eighty":-2.331154,"marketCap":43283399},{"date":"2025-07-11","current":-4.480408,"twenty":-3.326951,"median":-2.892641,"eighty":-2.341415,"marketCap":42868542},{"date":"2025-07-18","current":-4.841731,"twenty":-3.403834,"median":-2.918071,"eighty":-2.351675,"marketCap":46325682},{"date":"2025-07-25","current":-4.624937,"twenty":-3.433539,"median":-2.930636,"eighty":-2.361936,"marketCap":44251398},{"date":"2025-08-01","current":-4.176896,"twenty":-3.536633,"median":-2.935545,"eighty":-2.372196,"marketCap":39964544},{"date":"2025-08-08","current":-4.263614,"twenty":-3.615264,"median":-2.954985,"eighty":-2.392716,"marketCap":40794257},{"date":"2025-08-15","current":-4.12993,"twenty":-3.770777,"median":-2.969531,"eighty":-2.448122,"marketCap":42591970},{"date":"2025-08-22","current":-4.424925,"twenty":-4.171115,"median":-2.986997,"eighty":-2.477228,"marketCap":45634254},{"date":"2025-08-29","current":-4.00925,"twenty":-4.24627,"median":-2.996702,"eighty":-2.502733,"marketCap":41347400},{"date":"2025-09-05","current":-4.103112,"twenty":-4.234708,"median":-3.005439,"eighty":-2.533069,"marketCap":42315399},{"date":"2025-09-12","current":-4.317654,"twenty":-4.278067,"median":-3.026807,"eighty":-2.55483,"marketCap":44527969},{"date":"2025-09-19","current":-4.183566,"twenty":-4.278067,"median":-3.037068,"eighty":-2.570221,"marketCap":43145113},{"date":"2025-09-26","current":-4.12993,"twenty":-4.263614,"median":-3.042574,"eighty":-2.570989,"marketCap":42591970},{"date":"2025-10-03","current":-4.049477,"twenty":-4.249161,"median":-3.047328,"eighty":-2.593742,"marketCap":41762257},{"date":"2025-10-10","current":-4.049477,"twenty":-4.234708,"median":-3.057723,"eighty":-2.595872,"marketCap":41762257},{"date":"2025-10-14","current":-4.002546,"twenty":-4.230342,"median":-3.062228,"eighty":-2.602778,"marketCap":41278257}],"updateTime":1760539636389},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GRCE\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2569784748","title":"Grace Therapeutics announces presentation of Phase 3 STRIVE-ON safety trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2569784748","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569784748?lang=en_us&edition=fundamental","pubTime":"2025-09-22 20:21","pubTimestamp":1758543665,"startTime":"0","endTime":"0","summary":"Grace Therapeutics (GRCE) announced that results from its Pivotal Phase 3 STRIVE-ON Safety Trial of GTx-104 in aSAH were presented at the 2025 Neur...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/grace-therapeutics-announces-presentation-of-phase-3-strive-on-safety-trial-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/grace-therapeutics-announces-presentation-of-phase-3-strive-on-safety-trial-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BZ199S13.USD","BK4512","LENZ","LU1861219969.SGD","LU1861215975.USD","BK4139","LU1720051017.SGD","LU2360107325.USD","GRCE","LU1720051108.HKD","BK4141","LU1548497426.USD","BK4539","LU0348723411.USD","LU0724618433.USD","LU1854104046.USD","BK4605","LU1861220033.SGD","IE00BD6J9T35.USD","LU1854103824.USD","LU1861214812.USD","LU2357305700.SGD","BK4585","BK4588","LU0124384867.USD","ASST","ON","BK4007","LU1978683503.SGD","BK4009","LU2298322129.HKD"],"gpt_icon":0},{"id":"2569812647","title":"Grace Therapeutics Pivotal Phase 3 Strive-on Safety Trial Presented at 2025 Neurocritical Care Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2569812647","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569812647?lang=en_us&edition=fundamental","pubTime":"2025-09-22 20:00","pubTimestamp":1758542401,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250922:nTUA20L6R3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GRCE","BK4007"],"gpt_icon":0},{"id":"2567123901","title":"Grace Therapeutics Inc. Held Annual Stockholders Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2567123901","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567123901?lang=en_us&edition=fundamental","pubTime":"2025-09-13 04:13","pubTimestamp":1757708017,"startTime":"0","endTime":"0","summary":"Grace Therapeutics Inc. held its Annual Meeting of Stockholders on September 12, 2025. During the meeting, several proposals were voted on. The election of directors resulted in the appointment of Vimal Kavuru, A. Brian Davis, Prashant Kohli, S. George Kottayil, and Edward Neugeboren. The stockholders approved the advisory vote on executive officer compensation. Additionally, the appointment of KPMG LLP as the independent registered public accounting firm for the fiscal year ending March 31, 2026, was ratified.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Grace Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250912:nNDLbSr7dh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","GRCE"],"gpt_icon":0},{"id":"2562498937","title":"Grace Therapeutics Inc. Unveils Presentation on GTx-104 for aSAH Treatment, Highlighting Phase 3 Trial Success and Upcoming NDA Review","url":"https://stock-news.laohu8.com/highlight/detail?id=2562498937","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562498937?lang=en_us&edition=fundamental","pubTime":"2025-08-27 20:35","pubTimestamp":1756298137,"startTime":"0","endTime":"0","summary":"Grace Therapeutics Inc. Unveils Presentation on GTx-104 for aSAH Treatment, Highlighting Phase 3 Trial Success and Upcoming NDA Review. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Grace Therapeutics Inc. published the original content used to generate this news brief on August 27, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250827:nNDL6J9NRS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","GRCE"],"gpt_icon":0}],"pageSize":4,"totalPage":5,"pageCount":1,"totalSize":18,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/GRCE\",params:#limit:6,delay:false,,,undefined,":[]}}